Acorn Capital Advisors as of Dec. 31, 2025
Portfolio Holdings for Acorn Capital Advisors
Acorn Capital Advisors holds 21 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Terns Pharmaceuticals (TERN) | 23.9 | $71M | 1.7M | 40.40 | |
| Cg Oncology (CGON) | 15.9 | $47M | 1.1M | 41.52 | |
| Urogen Pharma (URGN) | 11.5 | $34M | 1.4M | 23.42 | |
| Trevi Therapeutics (TRVI) | 9.1 | $27M | 2.1M | 12.52 | |
| Puma Biotechnology (PBYI) | 8.3 | $25M | 4.1M | 5.95 | |
| Candel Therapeutics (CADL) | 4.9 | $15M | 2.6M | 5.65 | |
| Cybin Com New (HELP) | 4.4 | $13M | 1.6M | 8.18 | |
| Verastem (VSTM) | 3.8 | $11M | 1.5M | 7.72 | |
| Bicara Therapeutics (BCAX) | 3.7 | $11M | 643k | 16.83 | |
| Protara Therapeutics Com Stk (TARA) | 3.2 | $9.3M | 1.8M | 5.33 | |
| Onkure Therapeutics Class A Com (OKUR) | 2.8 | $8.2M | 2.8M | 2.90 | |
| Cardiff Oncology (CRDF) | 1.9 | $5.5M | 2.0M | 2.81 | |
| Athira Pharma Common Stock | 1.3 | $3.8M | 502k | 7.57 | |
| Jasper Therapeuritc (JSPR) | 1.1 | $3.3M | 1.8M | 1.83 | |
| Aura Biosciences (AURA) | 1.1 | $3.2M | 596k | 5.45 | |
| Aadi Bioscience (WHWK) | 0.9 | $2.8M | 1.1M | 2.42 | |
| Bioatla (BCAB) | 0.9 | $2.8M | 4.8M | 0.57 | |
| Q32 Bio (QTTB) | 0.6 | $1.6M | 493k | 3.32 | |
| X4 Pharmaceuticals | 0.4 | $1.1M | 273k | 4.00 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.3 | $977k | 405k | 2.41 | |
| Vyne Therapeutics (VYNE) | 0.0 | $827.070000 | 1.4k | 0.58 |
